These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15349816)

  • 1. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.
    Folgueras AR; Pendás AM; Sánchez LM; López-Otín C
    Int J Dev Biol; 2004; 48(5-6):411-24. PubMed ID: 15349816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The other side of MMPs: protective roles in tumor progression.
    Martin MD; Matrisian LM
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
    Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.
    Bachmeier BE; Iancu CM; Jochum M; Nerlich AG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):149-63. PubMed ID: 15757447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for MMP inhibition in cancer: innovations for the post-trial era.
    Overall CM; López-Otín C
    Nat Rev Cancer; 2002 Sep; 2(9):657-72. PubMed ID: 12209155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S; Murray GI
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
    Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
    Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and cancer.
    Cox G; O'Byrne KJ
    Anticancer Res; 2001; 21(6B):4207-19. PubMed ID: 11908674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.
    Arlt M; Kopitz C; Pennington C; Watson KL; Krell HW; Bode W; Gansbacher B; Khokha R; Edwards DR; Krüger A
    Cancer Res; 2002 Oct; 62(19):5543-50. PubMed ID: 12359766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
    Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and bladder cancer.
    Kanayama H
    J Med Invest; 2001 Feb; 48(1-2):31-43. PubMed ID: 11286015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
    Gialeli C; Theocharis AD; Karamanos NK
    FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and tumor progression.
    Freije JM; Balbín M; Pendás AM; Sánchez LM; Puente XS; López-Otín C
    Adv Exp Med Biol; 2003; 532():91-107. PubMed ID: 12908552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
    Davidson B; Reich R; Risberg B; Nesland JM
    Arkh Patol; 2002; 64(3):47-53. PubMed ID: 15338725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.